- Home
- TK vs SEPN Comparison
TK vs SEPN Comparison
Compare TK & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- SEPN
- Stock Information
- Founded
- TK 1973
- SEPN 2022
- Country
- TK Bermuda
- SEPN United States
- Employees
- TK N/A
- SEPN N/A
- Industry
- TK Marine Transportation
- SEPN
- Sector
- TK Consumer Discretionary
- SEPN
- Exchange
- TK Nasdaq
- SEPN NYSE
- Market Cap
- TK 554.2M
- SEPN 631.0M
- IPO Year
- TK 1995
- SEPN 2024
- Fundamental
- Price
- TK $6.68
- SEPN $6.10
- Analyst Decision
- TK
- SEPN Buy
- Analyst Count
- TK 0
- SEPN 4
- Target Price
- TK N/A
- SEPN $33.00
- AVG Volume (30 Days)
- TK 706.4K
- SEPN 420.0K
- Earning Date
- TK 05-08-2025
- SEPN 03-27-2025
- Dividend Yield
- TK N/A
- SEPN N/A
- EPS Growth
- TK N/A
- SEPN N/A
- EPS
- TK 1.42
- SEPN N/A
- Revenue
- TK $1,220,374,000.00
- SEPN $1,075,000.00
- Revenue This Year
- TK N/A
- SEPN N/A
- Revenue Next Year
- TK N/A
- SEPN N/A
- P/E Ratio
- TK $4.69
- SEPN N/A
- Revenue Growth
- TK N/A
- SEPN 611.92
- 52 Week Low
- TK $5.98
- SEPN $4.17
- 52 Week High
- TK $9.95
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- TK 49.83
- SEPN N/A
- Support Level
- TK $6.55
- SEPN N/A
- Resistance Level
- TK $6.75
- SEPN N/A
- Average True Range (ATR)
- TK 0.20
- SEPN 0.00
- MACD
- TK 0.03
- SEPN 0.00
- Stochastic Oscillator
- TK 64.53
- SEPN 0.00
About TK Teekay Corporation
Teekay Corp Ltd is engaged in providing international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services, and conventional tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.